Aimmune Therapeutics Inc logo

AIMT - Aimmune Therapeutics Inc News Story

$34.49 0.0  0.0%

Last Trade - 12/10/20

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £408k
Position in Universe th / 6846

LIVE MARKETS-Opening snapshot: risk off, Morphosis and SSE

Tue 13th October, 2020 9:11am
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Joice Alves (
and Julien Ponthus ( in London and Stefano Rebaudo
( and Danilo Masoni ( in
    After a three-day rally, it seems that it is going to be a risk-off session as investors are
growing more concerned about new waves of infections and more restrictions are being implemented
across Europe.
    Additionally, uncertainties around the U.S. elections and a rescue package to fight the
adverse impact of the pandemic are also keeping investors on their toes. 
    At an European level, the EU recovery fund might be delayed as some details are currently
being debated in Brussels.
    The STOXX 600 index is down 0.3%, with travel and leisure and banking stocks leading losses,
down respectively 1.6% and 1%.
    Morphosys  MORG.DE  is the worst performer, with shares down 9.9%, after the company
launched a convertible bond offering. Stocks in SSE  SSE.L  rose 4.2% after the company agreed
to sell its stake in West Yorkshire-based assets.
    So far, we've seen mixed reactions among Apple's suppliers ahead of an event where the U.S.
giant is expected to launch its latest iPhone. STMicro  STM.PA , Dialog Semi  DLGS.DE , Infineon
 IFXGn.DE , ASML  ASML.AS  stocks are down 0.8% to up 0.5%.
    (Stefano Rebaudo)
    European stocks are poised to open flat amid more worrying news on the coronavirus front and
uncertainties around the U.S. elections, stimulus package. 
    U.S. stock futures are trading slightly lower.
    The number of people being treated in French intensive care units for COVID-19 exceeded
1,500 on Monday for the first time since May 27, raising fears of local lockdowns being imposed
across the country*:nL8N2GX4RR. Meanwhile British Prime Minister Boris Johnson imposed a tiered
system of further restrictions on parts of England.*:nL8N2H30NJ
    The war against the pandemic continues: Roche  ROG.S  plans to start selling a higher-volume
COVID-19 antigen test for laboratories, which can provide results in 18 minutes, by the end of
the year.*:nFWN2H30TN Its shares are up 1.1% in premarket trade. 
    Relief Therapeutics  RLFB.S  said that more people who received a 50-year-old drug that the
Swiss company is seeking to re-purpose against COVID-19 were alive beyond 60 days than were
those who did not get the medicine.*:nL8N2H40NE
    On the M&A front Aimmune Therapeutics  AIMT.O  shareholders have backed Nestle's  NESN.S  $2
billion offer to gain full ownership of the first U.S.-approved peanut allergy treatment.*:nFWN2H30WX British utility SSE  SSE.L  agreed to sell its 50% stake in West Yorkshire-based
Ferrybridge and Skelton Grange assets for 995 million pounds ($1.30 billion) in cash, as part of
its strategy to dispose of non-core assets by autumn 2021.*:nL4N2H41LX
    Major French unions on Monday signed a keenly awaited labour deal with Airbus  AIR.PA 
covering job reductions and furloughs for production workers affected by coronavirus-blighted
demand for passenger jets.
    British clothing retailer French Connection Group  FCCN.L  said sales had halved, more than
tripling its underlying loss compared to the same period a year earlier.*:nL4N2H41LH
Yamana Gold stocks are admitted to the London stock exchange.
    (Stefano Rebaudo)
    European stock futures are almost flat, with their U.S. peers in negative territory, as
uncertainties provided by the coronavirus, the U.S. elections and stimulus as well as Brexit
keep risk sentiment in check.
    U.S. tech shares rallied on Wall Street overnight but, according some analysts, the
resurgence of the pandemic is boosting stay-at-home type of technology stocks.
    Asian stocks failed to take the cue from the U.S. as possibile tensions between Beijing and
Washington were also in view after the White House moved forward with three sales of advanced
weaponry to Taiwan. The move is going to anger China which considers Taiwan a renegade province.
    (Stefano Rebaudo)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.